Evaluation of drug release kinetics and physico-chemical characteristics of metronidazole floating beads based on calcium silicate and gas-forming agents.
In the present investigation metronidazole-loaded alginate beads consisting of calcium silicate as a porous carrier or NaHCO(3) as a gas-forming agent were prepared for local eradication of Helicobacter Pylori. Gelation method was used for preparation of conventional sodium alginate beads. Drug entrapment efficiency, drug loading, floating properties, drug release, crystallinity and release kinetic as well as morphology of the prepared beads were assessed. The silicate based beads showed slower release pattern, compared to the gas-forming beads due to network structure strengthening effect of the calcium silicate. Furthermore, the gas-forming-based beads had shorter initial buoyancy lag time, owing to the fact that the NaHCO(3) produced larger pores than those of silicate treated ones. Drug entrapment efficiency ranged between 61.7 and 93.1% for the prepared formulations. The maximum value of drug loading for gas-forming and silicate-based beads were 66.64% and 34.97%, respectively. Kinetically, release pattern of metronidazole in simulated gastric fluid from the beads fitted best to Reciprocal powered time, Weibull and log-probability models with the respect overall mean percentage error values of 4.50, 5.30 and 7.76. By and large, these systems can float in the gastric condition and control the drug release from the beads.
Javadzadeh
Yousef
Y
Faculty of Pharmacy and Drug Applied Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran. javadzadehy@yahoo.com
Hamedeyazdan
Sanaz
S
Adibkia
Khosro
K
Kiafar
Farhad
F
Zarrintan
Mohammad Hosein
MH
Barzegar-Jalali
Mohammad
M
D000464:Alginates / Q000737:chemistry; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000737:chemistry; D017610:Calcium Compounds / Q000737:chemistry*; D003460:Crystallization; D003692:Delayed-Action Preparations; D004337:Drug Carriers / Q000737:chemistry*; D016503:Drug Delivery Systems; D020723:Glucuronic Acid / Q000737:chemistry; D016481:Helicobacter Infections / Q000188:drug therapy; D016480:Helicobacter pylori / Q000187:drug effects; D006603:Hexuronic Acids / Q000737:chemistry; D007700:Kinetics; D008795:Metronidazole / Q000008:administration & dosage* / Q000737:chemistry; D017640:Silicates / Q000737:chemistry*; D017693:Sodium Bicarbonate / Q000737:chemistry
D000464:Alginates; D000890:Anti-Infective Agents; D017610:Calcium Compounds; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D006603:Hexuronic Acids; D017640:Silicates; D008795:Metronidazole; D020723:Glucuronic Acid; D017693:Sodium Bicarbonate; C031293:calcium silicate